$3.58
1.4%
Downside
Day's Volatility :9.72%
Upside
8.44%
84.92%
Downside
52 Weeks Volatility :87.97%
Upside
20.27%
Period | Euda Health Holdings Ltd | Index (Russel 2000) |
---|---|---|
3 Months | 97.45% | 0.0% |
6 Months | 148.08% | 0.0% |
1 Year | 567.24% | 0.0% |
3 Years | -10.01% | -20.2% |
Market Capitalization | 138.1M |
Book Value | - $0.3 |
Earnings Per Share (EPS) | -0.37 |
Profit Margin | -270.86% |
Operating Margin TTM | -106.87% |
Return On Assets TTM | -18.38% |
Return On Equity TTM | 0.0% |
Revenue TTM | 3.7M |
Revenue Per Share TTM | 0.16 |
Quarterly Revenue Growth YOY | -54.400000000000006% |
Gross Profit TTM | 3.4M |
EBITDA | -3.9M |
Diluted Eps TTM | -0.37 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 8.9M | - |
Net Income | 175.6K | - |
Net Profit Margin | 1.98% | - |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 10.5M | ↑ 18.81% |
Net Income | 864.8K | ↑ 392.57% |
Net Profit Margin | 8.2% | ↑ 6.22% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 9.8M | ↓ 6.67% |
Net Income | -24.9M | ↓ 2977.35% |
Net Profit Margin | -252.87% | ↓ 261.07% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 3.7M | ↓ 62.34% |
Net Income | -10.0M | ↓ 59.66% |
Net Profit Margin | -270.86% | ↓ 17.99% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.7M | ↓ 0.96% |
Net Income | -473.0K | ↑ 264.39% |
Net Profit Margin | -17.74% | ↓ 12.92% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.4M | ↓ 8.95% |
Net Income | -1.0M | ↑ 115.52% |
Net Profit Margin | -41.98% | ↓ 24.24% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.3M | ↓ 4.81% |
Net Income | -741.3K | ↓ 27.28% |
Net Profit Margin | -32.07% | ↑ 9.91% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.4M | ↑ 5.32% |
Net Income | -22.5M | ↑ 2936.03% |
Net Profit Margin | -924.54% | ↓ 892.47% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.4M | ↑ 0.0% |
Net Income | -22.5M | ↑ 0.0% |
Net Profit Margin | -924.54% | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.7M | ↓ 30.22% |
Net Income | -2.4M | ↓ 89.27% |
Net Profit Margin | -142.14% | ↑ 782.4% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 5.9M | - |
Total Liabilities | 6.2M | - |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 8.0M | ↑ 36.07% |
Total Liabilities | 7.4M | ↑ 19.42% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 25.6M | ↑ 220.4% |
Total Liabilities | 29.1M | ↑ 293.79% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 1.3M | ↓ 94.89% |
Total Liabilities | 8.8M | ↓ 69.82% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 6.7M | ↓ 92.3% |
Total Liabilities | 7.9M | ↑ 67.96% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 25.6M | ↑ 283.77% |
Total Liabilities | 29.1M | ↑ 266.55% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 25.6M | ↑ 0.0% |
Total Liabilities | 29.1M | ↑ 0.05% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 25.5M | ↓ 0.59% |
Total Liabilities | 31.4M | ↑ 7.83% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.3M | ↓ 94.86% |
Total Liabilities | 8.8M | ↓ 72.01% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 1.3M | ↑ 0.0% |
Total Liabilities | 8.8M | ↑ 0.0% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -411.9K | - |
Investing Cash Flow | 179.3K | - |
Financing Cash Flow | 212.5K | - |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 443.9K | ↓ 207.78% |
Investing Cash Flow | -356.2K | ↓ 298.6% |
Financing Cash Flow | -168.4K | ↓ 179.23% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -1.5M | ↓ 443.94% |
Investing Cash Flow | -268.2K | ↓ 24.7% |
Financing Cash Flow | 2.5M | ↓ 1578.23% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -337.0K | ↓ 37.57% |
Investing Cash Flow | -124.0K | - |
Financing Cash Flow | -1.4M | ↓ 351.93% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -965.4K | ↑ 186.5% |
Investing Cash Flow | -47.8K | ↓ 61.5% |
Financing Cash Flow | 1.0M | ↓ 173.62% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 667.5K | ↓ 169.14% |
Investing Cash Flow | -67.1K | ↑ 40.42% |
Financing Cash Flow | 130.0K | ↓ 87.13% |
Sell
Neutral
Buy
Euda Health Holdings Ltd is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Euda Health Holdings Ltd | 2.11% | 148.08% | 567.24% | -10.01% | -10.01% |
![]() Solventum Corp | 13.4% | -16.71% | -16.71% | -16.71% | -16.71% |
![]() Veeva Systems Inc. | 1.24% | -10.63% | -7.18% | -43.19% | 9.43% |
![]() Ge Healthcare Technologies Inc. | 2.46% | 9.25% | 3.22% | 32.12% | 32.12% |
![]() Healthequity Inc | -3.68% | 3.76% | 26.99% | 6.89% | -2.18% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Euda Health Holdings Ltd | NA | NA | NA | 0.0 | 0.0 | -0.18 | NA | -0.3 |
![]() Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
![]() Veeva Systems Inc. | 54.35 | 54.35 | 1.35 | 4.76 | 0.13 | 0.06 | NA | 30.25 |
![]() Ge Healthcare Technologies Inc. | 23.5 | 23.5 | 20.11 | 4.27 | 0.22 | 0.06 | 0.0 | 16.23 |
![]() Healthequity Inc | 85.91 | 85.91 | 2.29 | 2.19 | 0.04 | 0.03 | NA | 24.11 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Euda Health Holdings Ltd | NA | $138.1M | -10.01% | NA | -270.86% |
![]() Solventum Corp | Hold | $10.8B | -16.71% | NA | 15.73% |
![]() Veeva Systems Inc. | Buy | $29.8B | 9.43% | 54.35 | 22.34% |
![]() Ge Healthcare Technologies Inc. | Buy | $36.9B | 32.12% | 23.5 | 8.05% |
![]() Healthequity Inc | Buy | $6.9B | -2.18% | 85.91 | 7.71% |
Insights on Euda Health Holdings Ltd
Revenue is down for the last 2 quarters, 2.43M → 1.69M (in $), with an average decrease of 30.2% per quarter
Netprofit is up for the last 2 quarters, -22.50M → -2.41M (in $), with an average increase of 832.1% per quarter
Hudson Bay Capital Management LP
Yakira Capital Management, Inc.
XTX Topco Ltd
Walleye Trading Advisors, LLC
Geode Capital Management, LLC
Renaissance Technologies Corp
Organization | Euda Health Holdings Ltd |
Employees | 106 |
CEO | Dr. Wei Wen Chen |
Industry | Technology |